Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response

Antioxidants and Redox Signaling

Volumn 7, Issue 1-2, 2005, Pages 144-152

  Adcock, Ian M ^a   Cosio, Borja ^a   Tsaprouni, Loukia ^a   Barnes, Peter J ^a   Ito, Kazuhiro ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTATHIONE; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; HISTONE H1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STEROID RECEPTOR COACTIVATOR 1; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ACETYLATION; CHROMATIN STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEACETYLATION; DNA TRANSCRIPTION; DRUG MECHANISM; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ACETYLATION; ANIMALS; ANTIOXIDANTS; CHROMATIN; DNA; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HISTONE DEACETYLASES; HISTONES; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NF-KAPPA B; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, GLUCOCORTICOID; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 13244253907     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.144     Document Type: Review

References (78)

1. Adcock IM and Lane SJ. Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol 178: 347-355, 2003.
2. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, and Baldwin AS. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663, 2003.
3. Asaba K, Iwasaki Y, Yoshida M, Asai M, Oiso Y, Murohara T, and Hashimoto K. Attenuation by reactive oxygen species of glucocorticoid suppression on proopiomelanocortin gene expression in pituitary corticotroph cells. Endocrinology 145: 39-42, 2004.
4. Ashburner BP, Westerheide SD, and Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065-7077, 2001.
5. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107: 3-6, 2001.
6. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 343: 269-280, 2000.
7. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 117: 10S-14S, 2000.
8. Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167: 813-818, 2003.
9. Barnes PJ and Adcock IM. Transcription factors and asthma. Eur Respir J 12: 221-234, 1998.
10. Barnes PJ and Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 139: 359-370, 2003.
11. Barnes PJ and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
12. Belikov S, Gelius B, and Wrange O. Hormone-induced nucleosome positioning in the MMTV promoter is reversible. EMBO J 20: 2802-2811, 2001.
13. Bohm L, Schneeweiss FA, Sharan RN, and Feinendegen LE. Influence of histone acetylation on the modification of cytoplasmic and nuclear proteins by ADP-ribosylation in response to free radicals. Biochim Biophys Acta 1334: 149-154, 1997.
14. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, and Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 120: 1917-1922, 2001.
15. Chen L, Fischle W, Verdin E, and Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653-1657, 2001.
16. Culpitt SV, Maziak W, Loukidis S, Nightingale J A, Matthews JL, and Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1635-1639, 1999.
17. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, and Barnes PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 24-31, 2003.
18. Dai Y, Guo Y, Guo J, Pease LJ, Li J, Marcotte PA, Glaser KB, Tapang P, Albert DH, Richardson PL, Davidsen SK, and Michaelides MR. Indole amide hydroxamic acids as potent inhibitors of histone deacetylases. Bioorg Med Chem Lett 13: 1897-1901, 2003.
19. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, and Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97: 3919-3924, 2000.
20. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, and van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749, 2003.
21. Di Stefano A, Caramori G, Capelli A, Lusuardi M, Balbi B, Chung FK, Balbo R, Donner CF, Barnes PJ, and Adcock IM. Activation of NF-kappaB transcription factor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: A77, 2002.
22. Fischle W, Kiermer V, Dequiedt F, and Verdin E. The emerging role of class II histone deacetylases. Biochem Cell Biol 79: 337-348, 2001.
23. Forman HJ, Torres M, and Fukuto J. Redox signaling. Mol Cell Biochem 234-235: 49-62, 2002.
24. Fournel M, Trachy-Bourget MC, Van PT, Kalita A, Bonfils C, Beaulieu C, Frechette S, Leit S, Abou-Khalil E, Woo SH, Delorme D, MacLeod AR, Besterman JM, and Li Z. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors. Cancer Res 62: 4325-4330, 2002.
25. Galigniana MD, Piwien-Pilipuk G, and Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol 55: 317-323, 1999.
26. Gilmour PS, Rahman I, Donaldson K, and MacNee W. Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 284: L533-L540, 2003.
27. Hassa PO, Buerki C, Lombardi C, Imhof R, and Hottiger MO. Transcriptional coactivation of nuclear factor-κ-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278: 45145-45153, 2003.
28. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, and Barnes NC. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 165: 1592-1596, 2002.
29. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, and Cato AC. I-kappaB alpha independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 16: 4698-4707, 1997.
30. Ito K, Barnes PJ, and Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on Iysines 8 and 12. Mol Cell Biol 20: 6891-6903, 2000.
31. Ito K, Hanazawa T, Kharitonov SA, Tomita K, Barnes PJ, and Adcock IM. Tyrosine nitration and oxidative stress inhibit histone deactylase 2 activity and function. Am J Respir Crit Care Med 163: A575, 2001.
32. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, and Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 15: 1110-1112, 2001.
33. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, and Barnes PJ. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A 99: 8921-8926, 2002.
34. Iwata K, Tomita K, Sano H, Fujii Y, Yamasaki A, and Shimizu E. Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 218: 26-33, 2002.
35. Janknecht R and Hunter T. Versatile molecular glue. Transcriptional control. Curr Biol 6: 951-954, 1996.
36. Jenuwein T and Allis CD. Translating the histone code. Science 293: 1074-1080, 2001.
37. Kagoshima M, Wilcke T, Ito K, Tsaprouni L, Barnes PJ, Punchard N, and Adcock IM. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur J Pharmacol 429: 327-334, 2001.
38. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93: 487-490, 1998.
39. Keatings VM and Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 155: 449-453, 1997.
40. Kelly WK, O'Connor OA, and Marks PA. Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 11: 1695-1713, 2002.
41. Kharitonov SA and Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 7: 1-32, 2002.
42. 2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 273: 32670-32678, 1998.
43. Lee H, Rezai-Zadeh N, and Seto E. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol 24: 765-773, 2004.
44. Lee HL and Archer TK. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter. EMBO J 17: 1454-1466, 1998.
45. Li Q and Wrange O. Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol 15: 4375-4384, 1995.
46. Li X, Wong J, Tsai SY, Tsai MJ, and O'Malley BW. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23: 3763-3773, 2003.
47. Lopez AD and Murray CC. The global burden of disease, 1990-2020. Nat Med 4: 1241-1243, 1998.
48. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429: 195-207, 2001.
49. McKinsey TA, Zhang CL, and Olson EN. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev 11: 497-504, 2001.
50. Nasuhara Y, Adcock IM, Catley M, Barnes PJ, and Newton R. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. J Biol Chem 274: 19965-19972, 1999.
51. Ohmori Y, Schreiber RD, and Hamilton TA. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 272: 14899-14907, 1997.
52. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, and Makino I. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274: 10363-10371, 1999.
53. Paredi P, Kharitonov SA, and Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 166: S31-837, 2002.
54. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, and Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLB1/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276, 2001.
55. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 1: 291-315, 2002.
56. Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 64: 935-942, 2002.
57. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 36: 95-109, 2003.
58. Rahman I, Antonicelli F, and MacNee W. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 274: 5088-5096, 1999.
59. Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PK, and MacNee W. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappaB. Biochem Pharmacol 62: 787-794, 2001.
60. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, and Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541, 1998.
61. Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P, and Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20: 7168-7173, 2001.
62. Repine JE, Bast A, and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156: 341-357, 1997.
63. Rosenfeld MG and Glass CK. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276: 36865-36868, 2001.
64. Ryu H, Lee J, Olofsson BA, Mwidau A, Deodeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, and Ratan RR. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A 100: 4281-4286, 2003.
65. Saccani S and Natoli G. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16: 2219-2224, 2002.
66. Saccani S, Pantano S, and Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193: 1351-1359, 2001.
67. Saccani S, Pantano S, and Natoli G. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3: 69-75, 2002.
68. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of 1 kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
69. Tikoo K, Lau SS, and Monks TJ. Histone H3 phosphorylation is coupled to poly-(ADP-ribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells. Mol Pharmacol 60: 394-402, 2001.
70. Tomita K, Barnes PJ, and Adcock IM. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 301: 572-577, 2003.
71. Tsai SC and Seto E. Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem 277: 31826-31833, 2002.
72. Turlais F, Hardcastle A, Rowlands M, Newbatt Y, Bannister A, Kouzarides T, Workman P, and Aherne GW. High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate). Anal Biochem 298: 62-68, 2001.
73. Urnov FD and Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 20: 2991-3006, 2001.
74. Viatour P, Legrand-Poels S, Van Lint C, Warnier M, Merville MP, Gielen J, Piette J, Bours V, and Chariot A. Cytoplasmic IκBα Increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J Biol Chem 278: 46541-46548, 2003.
75. Waterborg JH. Steady-state levels of histone acetylation in Saccharomyces cerevisiae. J Biol Chem 275: 13007-13011, 2000.
76. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, and Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-659, 2003.
77. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.
78. Zlatanova J, Caiafa P, and Van Holde K. Linker histone binding and displacement: versatile mechanism for transcriptional regulation. FASEB J 14: 1697-1704, 2000.